Skip to main navigation

menu

Vision and Leadership
Science and Pipeline
Commitment
Investors
- « Back
People
Contact

Vision and Leadership
Science and Pipeline
Commitment
Investors
- « Back
People
Contact

for investors

Site - Investor Relations - 2nd Tier

Overview
Stock Information
- Stock Quote
- Analyst Coverage
News & Events
- Press Releases
- Presentations & Events
Governance
- Governance
- Committee Composition
Financials
- SEC Filings
- Reports & Results
Investor Resources

Site - Investor Relations - 3rd Tier

Overview
Stock Information
- Stock Quote
- Analyst Coverage
News & Events
- Press Releases
- Presentations & Events
Governance
- Governance
- Committee Composition
Financials
- SEC Filings
- Reports & Results
Investor Resources

Reports & Results

Annual Reports & Proxies

Date	Title
Apr 24, 2020	2020 Proxy Statement 470.2 KB
Mar 11, 2020	2019 Form 10-K 1.6 MB

Quarterly Results

Show all

2020

Q4	March 15, 2021 Ovid Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results, Provides Corporate Update for 2021 10-K Annual report which provides a comprehensive overview of the company for the past year
Q3	November 12, 2020 Ovid Therapeutics Reports Third Quarter 2020 Financial Results and Provides Corporate Update 10-Q Quarterly report which provides a continuing view of a company's financial position
Q2	Aug 10, 2020 Ovid Therapeutics Reports Second Quarter 2020 Financial Results and Provides Corporate Update 10-Q Quarterly report which provides a continuing view of a company's financial position
Q1	May 07, 2020 Ovid Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate Update 10-Q Quarterly report which provides a continuing view of a company's financial position

2019

Q4	March 11, 2020 Ovid Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results, Provides Corporate Update for 2020 10-K Annual report which provides a comprehensive overview of the company for the past year
Q3	Nov 08, 2019 Ovid Therapeutics Reports Third Quarter 2019 Financial Results and Recent Progress 10-Q Quarterly report which provides a continuing view of a company's financial position
Q2	Aug 07, 2019 Ovid Therapeutics Reports Second Quarter 2019 Financial Results and Highlights Recent Progress 10-Q Quarterly report which provides a continuing view of a company's financial position
Q1	May 7, 2019 Ovid Therapeutics Reports First Quarter 2019 Financial Results 10-Q Quarterly report which provides a continuing view of a company's financial position

2018

Q4	Mar 7, 2019 Ovid Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results 10-K Annual report which provides a comprehensive overview of the company for the past year
Q3	Nov 8, 2018 Ovid Therapeutics Reports Third Quarter 2018 Financial Results and Highlights Recent Clinical Progress 10-Q Quarterly report which provides a continuing view of a company's financial position
Q2	Aug 9, 2018 Ovid Therapeutics Reports Second Quarter 2018 Financial Results and Highlights Recent Clinical Progress 10-Q Quarterly report which provides a continuing view of a company's financial position
Q1	May 8, 2018 Ovid Therapeutics Reports First Quarter 2018 Financial Results and Corporate Progress 10-Q Quarterly report which provides a continuing view of a company's financial position

2017

Q4	Mar 29, 2018 Ovid Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results and Corporate Progress 10-K Annual report which provides a comprehensive overview of the company for the past year
Q3	Nov 9, 2017 Ovid Therapeutics Reports Third Quarter 2017 Financial Results and Corporate Progress 10-Q Quarterly report which provides a continuing view of a company's financial position
Q2	Aug 10, 2017 Ovid Therapeutics Reports Second Quarter 2017 Financial Results and Corporate Progress 10-Q Quarterly report which provides a continuing view of a company's financial position
Q1	Jun 13, 2017 Ovid Therapeutics Reports First Quarter 2017 Financial Results and Recent Corporate Progress 10-Q Quarterly report which provides a continuing view of a company's financial position

Site - Stockholder Tools

Print Page RSS Feeds Share Page E-mail Alerts

Site - Footer Nav

Contact
Privacy Policy
Terms & Conditions Agreement
Community Guidelines
Third-Party Websites

Site - Footer - Social icons

Linkedin
Twitter
Webcast
Youtube
Facebook

© Copyright 2021 Ovid Therapeutics.

Ovid, Ovid Therapeutics, Ovid Therapeutics Inc., and BoldMedicine are trademarks of Ovid Therapeutics Inc. All rights reserved.

Site - Footer - Social icons

Linkedin
Twitter
Webcast
Youtube
Facebook

Share on:
Facebook
Twitter
LinkedIn
Reddit
Digg
Google
StumbleUpon
What's This?
Share this page through your favorite social channel or email this page to a colleague.